Accendra Health
272 hedge funds and large institutions have $3.11B invested in Accendra Health in 2021 Q4 according to their latest regulatory filings, with 55 funds opening new positions, 65 increasing their positions, 117 reducing their positions, and 29 closing their positions.
90% more first-time investments, than exits
New positions opened: 55 | Existing positions closed: 29
39% more capital invested
Capital invested by funds: $2.23B → $3.11B (+$879M)
10% more funds holding
Funds holding: 247 → 272 (+25)
1.05% more ownership
Funds ownership: 94.64% → 95.69% (+1.1%)
44% less repeat investments, than reductions
Existing positions increased: 65 | Existing positions reduced: 117
79% less call options, than puts
Call options by funds: $17.4M | Put options by funds: $81.7M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
+$75.1M |
| 2 |
AIM
Artemis Investment Management
Edinburgh,
United Kingdom
|
+$30.4M |
| 3 |
BlackRock
New York
|
+$20.2M |
| 4 |
Millennium Management
New York
|
+$18M |
| 5 |
Goldman Sachs
New York
|
+$16.7M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Wells Fargo
San Francisco,
California
|
-$103M |
| 2 |
Wellington Management Group
Boston,
Massachusetts
|
-$18.9M |
| 3 |
HAI
Hennessy Advisors Inc
Novato,
California
|
-$14.7M |
| 4 |
Balyasny Asset Management
Chicago,
Illinois
|
-$10.7M |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$8.18M |
ACH Hedge Fund Activity: Q4 2021 in Review
272 of the 6,499 institutional investors tracked by Wall St. Rank reported a position in Accendra Health (ACH) for Q4 2021, worth a combined $3.11B — up 39% from $2.23B a quarter earlier.
Buyers outnumbered sellers: 55 funds opened new ACH positions and 29 closed out — a net gain of 26 holders — while 65 added to existing stakes and 117 trimmed.
The largest buyer was Fidelity Investments, adding an estimated $75.1M. The largest seller was Wells Fargo, cutting an estimated $103M.
- 272 institutional investors held Accendra Health (ACH) as of Q4 2021, up from 247 in Q3 2021.
- Funds reported $3.11B of Accendra Health stock for Q4 2021, up 39% quarter-over-quarter.
- 55 funds opened new Accendra Health positions in Q4 2021 and 29 closed out, a net change of +26 holders.
- The largest Accendra Health buyer in Q4 2021 was Fidelity Investments, an estimated $75.1M added.
- The largest Accendra Health seller in Q4 2021 was Wells Fargo, an estimated $103M sold.
Based on aggregated 13F filings for Q4 2021.